JPMorgan Chase & Co’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Sell
299,666
-4,646
-2% -$17K ﹤0.01% 3674
2025
Q1
$1.31M Buy
304,312
+23,315
+8% +$101K ﹤0.01% 3506
2024
Q4
$899K Buy
280,997
+75,054
+36% +$240K ﹤0.01% 3859
2024
Q3
$589K Buy
205,943
+106,823
+108% +$306K ﹤0.01% 3927
2024
Q2
$278K Sell
99,120
-67,505
-41% -$189K ﹤0.01% 4110
2024
Q1
$473K Buy
166,625
+120,161
+259% +$341K ﹤0.01% 3991
2023
Q4
$190K Sell
46,464
-1,582
-3% -$6.47K ﹤0.01% 4467
2023
Q3
$153K Sell
48,046
-7,643
-14% -$24.3K ﹤0.01% 4378
2023
Q2
$185K Sell
55,689
-214
-0.4% -$710 ﹤0.01% 4314
2023
Q1
$119K Buy
55,903
+15,122
+37% +$32.2K ﹤0.01% 4576
2022
Q4
$110K Sell
40,781
-24,407
-37% -$65.8K ﹤0.01% 4462
2022
Q3
$212K Buy
65,188
+3,598
+6% +$11.7K ﹤0.01% 4143
2022
Q2
$301K Buy
61,590
+10,777
+21% +$52.7K ﹤0.01% 4132
2022
Q1
$387K Buy
50,813
+19,932
+65% +$152K ﹤0.01% 4141
2021
Q4
$285K Sell
30,881
-33,352
-52% -$308K ﹤0.01% 4358
2021
Q3
$915K Sell
64,233
-55,491
-46% -$790K ﹤0.01% 3664
2021
Q2
$1.99M Buy
119,724
+52,013
+77% +$864K ﹤0.01% 3221
2021
Q1
$1.23M Buy
67,711
+4,985
+8% +$90.8K ﹤0.01% 3535
2020
Q4
$472K Buy
62,726
+47,702
+318% +$359K ﹤0.01% 3782
2020
Q3
$58K Sell
15,024
-3,278
-18% -$12.7K ﹤0.01% 4247
2020
Q2
$70K Sell
18,302
-1,726
-9% -$6.6K ﹤0.01% 4086
2020
Q1
$65K Buy
20,028
+5,852
+41% +$19K ﹤0.01% 4068
2019
Q4
$69K Buy
14,176
+10,722
+310% +$52.2K ﹤0.01% 4138
2019
Q3
$23K Buy
3,454
+560
+19% +$3.73K ﹤0.01% 4451
2019
Q2
$22K Buy
2,894
+2,094
+262% +$15.9K ﹤0.01% 4498
2019
Q1
$6K Buy
+800
New +$6K ﹤0.01% 4695